highmark glp-1 coverage Wegovy requirements vary between UnitedHealth, Kaiser Blog | Discover Your Weight

While oral semaglutide has been available for diabetes (as Rybelsus), this approval makes Wegovy the first GLP-1 pill indicated for weight loss

You can benefit from retatrutide therapy if: You are obese (BMI 30 kg/m or more) or overweight (BMI 27 kg/m or more) with at least one weight-related health condition

Researchers analyzed 59,293 unique public Facebook posts discussing GLP-1 RA medications

This is higher than other GLP-1s, which had discontinuation rates of 6.1% (tirzepatide), 8.0% (semaglutide) and 10.3% (orforglipron)

After significant weight loss, some patients may qualify for procedures such as panniculectomy or body contouring to remove excess skin

Magnesium has a mild stool-softening effect and is generally well-tolerated